GlassScriptPhysician profile
Robert Felte
NPI 1073956728
$11,274.87
in general payments reported to CMS, 2019-2025
14 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,041 · 2021: $7,661 · 2022: $556 · 2023: $371 · 2024: $196 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.36 |
| Travel and Lodging | $249.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,581.50 | 2020-2024 | |
| Medtronic, INC. | $1,054.93 | 2021-2025 | Ligasure, Signia |
| Intra-Sana Laboratories | $259.35 | 2021 | |
| W. L. Gore & Associates, INC. | $86.09 | 2021 | |
| Teleflex LLC | $62.30 | 2023 | Kmedic |
| Baxter Healthcare | $62.30 | 2023 | Tisseel |
| Heron Therapeutics, INC. | $29.05 | 2023 | Zynrelef |
| Standard Bariatrics, INC. | $24.29 | 2022 | |
| Phathom Pharmaceuticals, INC. | $22.24 | 2024 | Voquezna |
| Olympus America INC. | $20.47 | 2021 | |
| Daiichi Sankyo INC. | $19.25 | 2022 | |
| Redhill Biopharma INC. | $19.19 | 2021 | |
| Novo Nordisk INC | $17.37 | 2023 | |
| Currax Pharmaceuticals LLC | $16.54 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Felte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.